Strides Pharma Shares Hit 52-Week High on Tentative USFDA Approval
Stride Pharma shares hit a 52-week high of Rs 522.75 on 15 September after its wholly owned subsidiary, Stride Pharma Global Pte. Ltd., received tentative...
Tag : Strides Pharma Science Ltd
Strides Pharma to Sell Manufacturing Unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday declared that it had entered a binding contract to sell the biologics Unit-3 manufacturing facility of its associate company Stelis...
Stride Pharma Science June Quarter Net Loss Narrows to Rs 163 Crore
Strides Pharma Science Ltd has reported a consolidated net loss of Rs 163.4 crore in the first quarter ended in June 2022, compensated by higher...